Tandem Diabetes Care Profit Margin 2012-2024 | TNDM

Current and historical gross margin, operating margin and net profit margin for Tandem Diabetes Care (TNDM) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Tandem Diabetes Care net profit margin as of September 30, 2024 is -14.84%.
Tandem Diabetes Care Annual Profit Margins
Tandem Diabetes Care Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.889B $0.748B
Tandem Diabetes Care, Inc. designs, develops and markets products for people with insulin-dependent diabetes. The company's flagship product, the t:slim X2 Insulin Delivery System, or t:slim X2, is based on its proprietary technology platform. Per the company, t:slim X2 is the smallest durable insulin pump available and is also the only available pump capable of remote feature updates.Tandem Diabetes also offers t:flex insulin delivery system which includes t:flex pump, its 480-unit disposable insulin cartridge, an infusion set, t:lock cartridge and infusion set products, various pump accessories along with t:slim X2 with G5 integration.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $191.744B 23.39
Intuitive Surgical (ISRG) United States $189.359B 99.00
Alcon (ALC) Switzerland $42.325B 28.32
Edwards Lifesciences (EW) United States $41.221B 26.18
IQVIA Holdings (IQV) United States $34.674B 19.10
IDEXX Laboratories (IDXX) United States $34.378B 40.49
DexCom (DXCM) United States $29.791B 44.87
STERIS (STE) Ireland $21.428B 24.67
SONOVA HOLDING (SONVY) Switzerland $21.334B 0.00
Waters (WAT) United States $21.106B 31.21
Hologic (HOLX) United States $18.301B 19.31
Fresenius Medical Care AG KGaA (FMS) Germany $12.981B 13.32
Sysmex ADR (SSMXY) Japan $12.562B 39.39
Globus Medical (GMED) United States $11.143B 28.22
Penumbra (PEN) United States $9.229B 90.41
Teleflex (TFX) United States $9.030B 14.40
Masimo (MASI) United States $8.611B 41.67
Glaukos (GKOS) United States $7.553B 0.00
PROCEPT BioRobotics (PRCT) United States $4.748B 0.00
Integer Holdings (ITGR) United States $4.512B 25.58
Inari Medical (NARI) United States $3.004B 0.00
LivaNova (LIVN) United Kingdom $2.852B 16.47
Veracyte (VCYT) United States $2.845B 85.37
TransMedics (TMDX) United States $2.716B 86.10
Nihon Kohden (NHNKY) Japan $2.378B 18.07
Elekta AB (EKTAY) Sweden $2.194B 17.88
RxSight (RXST) United States $1.800B 0.00
Integra LifeSciences Holdings (IART) United States $1.735B 9.07
Alphatec Holdings (ATEC) United States $1.208B 0.00
OPKO Health (OPK) United States $1.119B 0.00
Artivion (AORT) United States $1.118B 74.08
Pulse Biosciences (PLSE) United States $1.014B 0.00
Paragon 28 (FNA) United States $0.854B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.833B 14.16
ORTHOFIX MEDICAL INC (OFIX) United States $0.699B 0.00
IRadimed (IRMD) United States $0.647B 34.97
AxoGen (AXGN) United States $0.563B 0.00
Mesa Laboratories (MLAB) United States $0.560B 13.19
OrthoPediatrics (KIDS) United States $0.552B 0.00
SiBone (SIBN) United States $0.518B 0.00
Treace Medical Concepts (TMCI) United States $0.459B 0.00
Pacific Biosciences Of California (PACB) United States $0.430B 0.00
Tactile Systems Technology (TCMD) United States $0.379B 20.49
Semler Scientific (SMLR) United States $0.343B 23.03
CVRx (CVRX) United States $0.331B 0.00
Delcath Systems (DCTH) United States $0.311B 0.00
ClearPoint Neuro (CLPT) United States $0.296B 0.00
AngioDynamics (ANGO) United States $0.280B 0.00
NeuroPace (NPCE) United States $0.267B 0.00
Inogen (INGN) United States $0.227B 0.00
Sight Sciences (SGHT) United States $0.190B 0.00
Accuray (ARAY) United States $0.171B 0.00
Atossa Genetics (ATOS) United States $0.161B 0.00
Nevro (NVRO) United States $0.161B 0.00
Alpha Tau Medical (DRTS) Israel $0.160B 0.00
KORU Medical Systems (KRMD) United States $0.144B 0.00
Sensus Healthcare (SRTS) United States $0.138B 14.75
Spectral Diagnostics (EDTXF) Canada $0.112B 0.00
EDAP TMS S.A (EDAP) France $0.088B 0.00
WORK Medical Technology Group (WOK) China $0.086B 0.00
LENSAR (LNSR) United States $0.084B 0.00
908 Devices (MASS) United States $0.082B 0.00
Covalon Technologies (CVALF) Canada $0.079B 0.00
Monogram Orthopaedics (MGRM) United States $0.068B 0.00
InspireMD (NSPR) Israel $0.068B 0.00
Hyperfine (HYPR) United States $0.061B 0.00
EnVVeno Medical (NVNO) United States $0.058B 0.00
Lucid Diagnostics (LUCD) United States $0.056B 0.00
Vicarious Surgical (RBOT) United States $0.055B 0.00
Rapid Micro Biosystems (RPID) United States $0.046B 0.00
Accelerate Diagnostics (AXDX) United States $0.045B 0.00
Adagio Medical Holdings (ADGM) United States $0.040B 0.00
Envoy Medical (COCH) United States $0.039B 0.00
Biosig Technologies (BSGM) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.027B 0.00
Spectral AI (MDAI) United States $0.026B 0.00
Neuronetics (STIM) United States $0.024B 0.00
NexGel (NXGL) United States $0.021B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Baird Medical Investment Holdings (BDMD) $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
Autonomix Medical (AMIX) United States $0.014B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
Pixie Dust Technologies (PXDT) Japan $0.009B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Avinger (AVGR) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00